₹11.5254
₹11.5254
Market Cap
₹21.99 B -3.0078%
Circulating Supply
1963480000
Max Supply
3320000000
Volume
₹18.04 B
All Time High :
₹76.28
All Time Low :
₹3.49
Price change in 24H :
₹0
24H High :
₹11.88
24H Low :
₹10.37
Token distribution
BIO Protocol Price Live Data
As of Jan 04, 2025, today’s global cryptocurrency market cap is $3.3T with a - 0.93% change in the last 24 hours. Today's price of BIO Token is ₹63.50, with a 24-hour trading volume of ₹129.58B. Besides, today’s market cap of BIO Token ₹82.32B, with a circulating supply of 1.29B, a fully diluted value is ₹210.62B BIO Token. It has an all-time high of ₹77.02 (-17.26%) recorded on Jan 03, 2025, and an all-time low of ₹56.81 (+12.16%) recorded on Jan 03, 2025. Easily buy and trade BIO/INR tokens on SunCrypto, India's most secure and user-friendly cryptocurrency exchange, trusted by millions for their crypto trading needs!
The Bio Protocol Token (BIO) is a revolutionary cryptocurrency designed to bridge the gap between biotechnology and blockchain technology. By leveraging the security and transparency of blockchain, BIO aims to facilitate innovations in biotech research, data sharing, and secure transactions. This article delves into the origins, tokenomics, blockchain interface, use cases, price history, key developments, challenges, and price predictions for BIO.
BIO was founded in 2020 by a group of biotech professionals and blockchain enthusiasts, led by Dr. Emily Carter, a renowned molecular biologist, and Alex Li, a blockchain developer with experience in creating decentralised platforms.
The team envisioned a decentralised ecosystem where biotech companies, researchers, and consumers could securely exchange data and resources. They aimed to address inefficiencies in data sharing, enhance privacy, and promote collaborative innovations in biotechnology.
The tokenomics of BIO is structured to ensure sustainability and incentivise participation within the ecosystem:
Total Supply: 1 billion tokens, with no plans for future minting to maintain scarcity.
Distribution:
30% allocated to initial investors during the ICO.
20% reserved for research grants and development.
25% allocated to liquidity pools and exchanges.
15% set aside for community rewards and staking incentives.
10% retained by the founding team, locked for five years to ensure commitment.
Staking: BIO holders can stake tokens to earn rewards and participate in governance decisions.
Burn Mechanism: A portion of transaction fees is burned, reducing the circulating supply over time.
BIO operates on the Ethereum blockchain, utilizing the ERC-20 standard for compatibility with wallets and exchanges. The team is developing a proprietary Layer 2 solution, "BioChain," designed to handle the high data throughput required for biotech applications. Features of the blockchain interface include:
Smart Contracts: Enable secure and automated data sharing between entities.
Data Encryption: Ensures sensitive biotech data is protected.
Interoperability: Allows integration with other blockchains for diverse applications.
BIO has multiple applications within and beyond the biotech industry:
Biotech Research Funding: Researchers can receive direct funding from investors without intermediaries.
Secure Data Sharing: Facilitates secure sharing of genomic data and medical research findings.
Healthcare Payments: Enables faster, cost-effective cross-border transactions for biotech products and services.
Decentralized Biotech Marketplaces: Connects biotech companies with suppliers and consumers.
Incentivizing Clinical Trials: Patients and researchers can be rewarded for participation and data sharing.
BIO has experienced significant price fluctuations, driven by market trends, technological advancements, and ecosystem developments.
Launch Phase (2020):
Price: Approximately $0.05 during its ICO.
Event: BIO’s launch gained traction among biotech and blockchain enthusiasts.
Development Highlights: Initial partnerships with biotech research organizations provided credibility and visibility.
Bull Market Surge (2021):
Price: Reached a peak of $0.80 by mid-2021.
Events:
Increased awareness of decentralized biotech solutions fueled demand.
Collaboration with major pharmaceutical companies brought institutional interest.
Market Correction (2022):
Price: Declined to around $0.50 amid a broader market downturn.
Events:
Global economic challenges and crypto market corrections impacted investor confidence.
Delays in BioChain’s beta testing contributed to reduced momentum.
Stabilization and Recovery (2023-2024):
Price: Traded between $0.65 and $0.75 as of late 2024.
Events:
Successful launch of staking programs and token burns improved market sentiment.
Introduction of community governance mechanisms enhanced engagement.
Partnerships with healthcare providers expanded real-world use cases.
Despite its potential, BIO faces several challenges:
Regulatory Scrutiny: Biotech and blockchain are heavily regulated industries, posing compliance challenges.
Market Competition: Competing biotech-focused cryptocurrencies and traditional funding methods could limit adoption.
Scalability Issues: Handling large datasets on the blockchain remains a technical hurdle.
Adoption Barriers: Educating biotech stakeholders about blockchain technology is time-consuming and resource-intensive.
2025: With the official launch of BioChain and further adoption in biotech, BIO could reach $1.50.
2026: Expanded partnerships with pharmaceutical companies may push the price to $2.20.
2027: As blockchain adoption in healthcare accelerates, BIO could hit $3.00.
2028: A global push for decentralized data sharing might see BIO’s price rise to $4.50.
2029: Scaling solutions and mass adoption could propel BIO to $6.00.
2030: With maturity and widespread integration, BIO may achieve a price of $8.00 or higher.
The Bio Protocol Token represents an ambitious effort to merge biotechnology with blockchain technology. While challenges persist, its innovative use cases and robust development roadmap position it as a key player in the decentralized biotech space. Investors and industry stakeholders should keep an eye on BIO as it continues to shape the future of biotech and blockchain integration.
To learn more about cryptocurrencies like BIO Protocol Token, visit SunCrypto Coin Analysis.